Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1923 1
1977 1
1978 1
1980 1
1981 2
1982 1
1984 2
1985 5
1986 2
1987 9
1988 8
1989 11
1990 13
1991 16
1992 17
1993 19
1994 18
1995 18
1996 11
1997 8
1998 13
1999 18
2000 9
2001 15
2002 10
2003 4
2004 6
2005 7
2006 9
2007 10
2008 2
2009 5
2010 14
2011 14
2012 5
2013 8
2014 8
2015 8
2016 7
2017 8
2018 13
2019 12
2020 8
2021 10
2022 5
2023 4
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

376 results

Results by year

Filters applied: . Clear all
Page 1
A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study.
Spunt SL, Million L, Chi YY, Anderson J, Tian J, Hibbitts E, Coffin C, McCarville MB, Randall RL, Parham DM, Black JO, Kao SC, Hayes-Jordan A, Wolden S, Laurie F, Speights R, Kawashima E, Skapek SX, Meyer W, Pappo AS, Hawkins DS. Spunt SL, et al. Among authors: parham dm. Lancet Oncol. 2020 Jan;21(1):145-161. doi: 10.1016/S1470-2045(19)30672-2. Epub 2019 Nov 27. Lancet Oncol. 2020. PMID: 31786124 Free PMC article.
Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803.
Arndt CA, Stoner JA, Hawkins DS, Rodeberg DA, Hayes-Jordan AA, Paidas CN, Parham DM, Teot LA, Wharam MD, Breneman JC, Donaldson SS, Anderson JR, Meyer WH. Arndt CA, et al. Among authors: parham dm. J Clin Oncol. 2009 Nov 1;27(31):5182-8. doi: 10.1200/JCO.2009.22.3768. Epub 2009 Sep 21. J Clin Oncol. 2009. PMID: 19770373 Free PMC article. Clinical Trial.
Extrarenal Wilms' tumor.
Fernandes ET, Kumar M, Douglass EC, Wilimas J, Parham DM, Rao BN. Fernandes ET, et al. Among authors: parham dm. J Pediatr Surg. 1989 May;24(5):483-5. doi: 10.1016/s0022-3468(89)80407-5. J Pediatr Surg. 1989. PMID: 2544714 Review.
Pediatric Sarcomas: The Next Generation of Molecular Studies.
Giannikopoulos P, Parham DM. Giannikopoulos P, et al. Among authors: parham dm. Cancers (Basel). 2022 May 20;14(10):2515. doi: 10.3390/cancers14102515. Cancers (Basel). 2022. PMID: 35626119 Free PMC article. Review.
Anti-CD45.
Parham DM. Parham DM. Am J Surg Pathol. 1995 Jun;19(6):732-4. doi: 10.1097/00000478-199506000-00018. Am J Surg Pathol. 1995. PMID: 7755161 No abstract available.
Enid Gilbert Barness: In Memoriam.
Parham D. Parham D. Pediatr Dev Pathol. 2022 Sep-Oct;25(5):497-498. doi: 10.1177/10935266221120229. Pediatr Dev Pathol. 2022. PMID: 36123784 No abstract available.
Myogenic tumors in children and adolescents.
Parham DM, Alaggio R, Coffin CM. Parham DM, et al. Pediatr Dev Pathol. 2012;15(1 Suppl):211-38. doi: 10.2350/10-12-0953-PB.1. Pediatr Dev Pathol. 2012. PMID: 22420729 Review.
376 results